3 hours MBX Biosciences (NYSE:MBX) Now Covered by JPMorgan Chase & Co. MarketBeat
JPMorgan Chase & Co. began coverage on shares of MBX Biosciences in a report on Tuesday. They issued an “overweight” rating and a $30.00 price target on the stock.
JPMorgan Chase & Co. began coverage on shares of MBX Biosciences in a report on Tuesday. They issued an “overweight” rating and a $30.00 price target on the stock.